Ivermectin: a pathway out of the pandemic or another dead end?

Expert Rev Anti Infect Ther. 2022 May;20(5):645-647. doi: 10.1080/14787210.2022.2012154. Epub 2021 Dec 13.

Authors

Daniel Echeverría-Esnal^{1

2}, Santiago Grau^{1

2

3}

Affiliations

¹ Pharmacy Department, Hospital Del Mar, Parc de Salut Mar, Barcelona, Spain.
² Infectious Pathology and Antimicrobials Research Group (Ipar) Institut Hospital Del Mar d'Investigacions Mèdiques (Imim), Barcelona, Spain.
³ Universitat Autònoma de Barcelona, Barcelona, Spain.

PMID: 34894986
DOI: 10.1080/14787210.2022.2012154

No abstract available

Keywords: Antimicrobial consumption; COVID-19 pandemic; antibiotic; antimicrobial prescribing; clinical practice.

Publication types

Editorial

MeSH terms

COVID-19*
Humans
Ivermectin / therapeutic use
Pandemics*
SARS-CoV-2

Substances

Ivermectin